Remission rates not affected by adjuvant immunoadsorption in pemphigus

In patients with pemphigus vulgaris and pemphigus foliaceus, adjuvant immunoadsorption did not lessen the time to clinical remission, according to a study.
“Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are severe autoimmune blistering skin diseases characterized by IgG autoantibodies against the two desmosomal proteins desmoglein (Dsg)1 and Dsg3,” Nina van Beek, MD, of the department of dermatology, allergology and venereology at University of Lübeck in Lübeck, Germany, and colleagues wrote. “In addition, autoantibodies to other target antigens, including

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart